No, systemic corticosteroids should NOT be given for uncomplicated acute bronchitis in otherwise healthy patients.
For an otherwise healthy adult with uncomplicated acute bronchitis and no chronic lung disease, do not prescribe systemic corticosteroids—they provide no benefit and expose patients to unnecessary harm.
Key Distinction: Acute Bronchitis vs. Chronic Bronchitis/COPD
The evidence provided addresses chronic bronchitis and COPD exacerbations, not uncomplicated acute bronchitis in healthy patients. This is a critical distinction:
Acute Bronchitis (Your Question)
- No corticosteroids indicated 1
- Self-limiting viral illness lasting 2-3 weeks 2, 3
- Recent high-quality evidence shows no benefit from oral or inhaled corticosteroids 4
- A 2025 prospective cohort study found that systemic corticosteroids in patients with lower respiratory tract infections were associated with increased antibiotic prescribing (adjusted OR 1.37) but showed no reduction in cough duration, severity, or need for follow-up visits 4
Chronic Bronchitis/COPD Exacerbations (Different Condition)
- Corticosteroids ARE recommended for acute exacerbations 5
- Short course (10-15 days) of systemic corticosteroids for exacerbations 5
- This does NOT apply to your patient without chronic lung disease
Evidence Against Corticosteroid Use in Acute Bronchitis
The 2020 CHEST Expert Panel explicitly recommends against routine prescription of oral corticosteroids for immunocompetent adults with acute bronchitis 1. This is an ungraded consensus-based statement from the most recent and relevant guideline.
A 2013 systematic review of inhaled corticosteroids for acute respiratory tract infections found:
- Mixed results with insufficient evidence to recommend routine use 6
- Only 4 trials with 335 participants
- Most trials had unclear risk of bias
- Outcomes too heterogeneous to meta-analyze
Most recent evidence (2025) confirms corticosteroids provide no clinical benefit for acute bronchitis 3, 4.
What You Should Do Instead
Rule out conditions that DO require corticosteroids:
- COPD exacerbation (history of chronic lung disease, FEV1 <50%)
- Asthma exacerbation (wheezing, bronchial hyperreactivity)
- These require different management algorithms
Provide appropriate management:
Reassess if worsening:
- Consider bacterial superinfection requiring antibiotics 1
- Reconsider alternative diagnoses (pneumonia, pertussis, exacerbation of underlying lung disease)
Common Pitfalls to Avoid
- Don't confuse acute bronchitis with COPD exacerbation: The guidelines citing corticosteroid benefits 7, 5, 8 specifically address chronic bronchitis/COPD, not acute bronchitis in healthy patients
- Don't prescribe "just in case": Corticosteroids have well-documented harms (hyperglycemia, weight gain, infection risk, adrenal suppression) without benefit in this population 5
- Don't use the term "bronchitis": Call it a "chest cold" to reduce patient expectations for medication 2, 3
The evidence is clear: systemic corticosteroids have no role in managing uncomplicated acute bronchitis in otherwise healthy adults.